Abstract:Introduction: Gut microbiota have been linked to modulating susceptibility to Type 1 diabetes; however, there are many ways in which the microbiota interact with host cells, including through microbial ligand binding to intracellular inflammasomes (large multi-subunit proteins) to initiate immune responses. NLRP6, a microbe-recognizing inflammasome protein, is highly expressed by intestinal epithelial cells and can alter susceptibility to cancer, obesity and Crohn's disease; however, the role of NLRP6 in modulating susceptibility to autoimmune diabetes, was previously unknown. Methods: We generated NLRP6-deficient Non-obese diabetic (NOD) mice to study the effect of NLRP6-deficiency on the immune cells and susceptibility to Type 1 diabetes development. Results: NLRP6-deficient mice exhibited an expansion of CD103+ B cells and were protected from type 1 diabetes. Moreover, NLRP6-deficient CD103+ B cells express regulatory markers, secreted higher concentrations of IL-10 and TGFb1 cytokines and suppressed diabetogenic T cell proliferation, compared to NLRP6-sufficient CD103+ B cells. Microarray analysis of NLRP6-sufficient and -deficient CD103+ B cells identified 79 significantly different genes including genes regulated by lipopolysaccharide (LPS), tretinoin, IL-10 and TGFb, which was confirmed in vitro following LPS stimulation. Furthermore, microbiota from NLRP6-deficient mice induced CD103+ B cells in colonized NLRP6-sufficient germ-free mice; however, the long-term maintenance of the CD103+ B cells required the absence of NLRP6 in the hosts, or continued exposure to microbiota from NLRP6-deficient mice. Discussion: Together, our data indicate that NLRP6 deficiency promotes expansion and maintenance of a novel TGF -dependent CD103+ Breg population. Thus, targeting NLRP6 therapeutically may prove clinically useful.

Microbial ligand-independent regulation of lymphopoiesis by NOD1

NOD1 ligand administration restores optimal steady-state hematopoiesis in germ-free mice

Recognition of Gut Microbiota by NOD2 is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes.

Nod1 Promotes Colorectal Carcinogenesis by Regulating the Immunosuppressive Functions of Tumor-Infiltrating Myeloid Cells

NOD1 and NOD2: Essential Monitoring Partners in the Innate Immune System

YOD1 sustains NOD2-mediated protective signaling in colitis by stabilizing RIPK2

Downregulated NDR1 Protein Kinase Inhibits Innate Immune Response by Initiating an Mir146a-Stat1 Feedback Loop

NOD2 Regulates CXCR3-dependent CD8+ T Cell Accumulation in Intestinal Tissues with Acute Injury.

Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection

Enhanced TLR-induced NF-κB Signaling and Type I Interferon Responses in NLRC5 Deficient Mice

An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid

NOD1 in the interplay between microbiota and gastrointestinal immune adaptations

NOD proteins and immune response

Mycoplasma hyopneumoniae Infection Activates the NOD1 Signaling Pathway to Modulate Inflammation

Multifaceted Functions of NOD-Like Receptor Proteins in Myeloid Cells at the Intersection of Innate and Adaptive Immunity

MyD88 protein destabilization mitigates NF-κB-dependent protection against macrophage apoptosis

NLRP10 Enhances CD4+ T-Cell-Mediated IFNγ Response via Regulation of Dendritic Cell-Derived IL-12 Release

Palmitoylation of NOD1 and NOD2 is Required for Bacterial Sensing

NLRP6 deficiency expands a novel CD103+ B cell population that confers immune tolerance in NOD mice

NOD2-mediated dual negative regulation of inflammatory responses triggered by TLRs in the gastrointestinal tract

Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages